Fehrman-Ekholm I - Search Results

1

Helldén A, Odar-Cederlöf I, Larsson K, Fehrman-Ekholm I, Lindén T. Helldén A, et al. BMJ. 2007 Dec 22;335(7633):1305. doi: 10.1136/bmj.39408.393137.BE. BMJ. 2007. PMID: 18156240 Free PMC article.

2

The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assay.

Ersson C, Odar-Cederlöf I, Fehrman-Ekholm I, Möller L. Ersson C, et al. Among authors: fehrman ekholm i. Hemodial Int. 2013 Jul;17(3):366-73. doi: 10.1111/hdi.12008. Epub 2012 Dec 20. Hemodial Int. 2013. PMID: 23279066

3

Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration.

Fehrman-Ekholm I, Lotsander A, Logan K, Dunge D, Odar-Cederlöf I, Kallner A. Fehrman-Ekholm I, et al. Scand J Urol Nephrol. 2008;42(1):74-80. doi: 10.1080/00365590701514266. Scand J Urol Nephrol. 2008. PMID: 18210337

4

Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance.

Fehrman-Ekholm I, Skeppholm L. Fehrman-Ekholm I, et al. Scand J Urol Nephrol. 2004;38(1):73-7. doi: 10.1080/00365590310015750. Scand J Urol Nephrol. 2004. PMID: 15204431

5

Recovery of renal function after one-year of dialysis treatment: case report and registry data.

Fehrman-Ekholm I, Bergenhag AC, Heimburger O, Schön S. Fehrman-Ekholm I, et al. Int J Nephrol. 2010 Jun 17;2010:817836. doi: 10.4061/2010/817836. Int J Nephrol. 2010. PMID: 21188240 Free PMC article.

6

Antibodies in alloimmunized uraemic patients treated with recombinant erythropoietin.

Fehrman-Ekholm I, Sumitran-Karuppan S. Fehrman-Ekholm I, et al. Transpl Int. 1994;7 Suppl 1:S290-3. doi: 10.1111/j.1432-2277.1994.tb01370.x. Transpl Int. 1994. PMID: 11271228

7

Associations between circulating inflammatory markers and residual renal function in CRF patients.

Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Pecoits-Filho R, et al. Am J Kidney Dis. 2003 Jun;41(6):1212-8. doi: 10.1016/s0272-6386(03)00353-6. Am J Kidney Dis. 2003. PMID: 12776273

8

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P. Snaedal S, et al. Am J Kidney Dis. 2009 Jun;53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008. Epub 2009 Apr 25. Am J Kidney Dis. 2009. PMID: 19394732

9

No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up.

Fehrman-Ekholm I, Dunér F, Brink B, Tydén G, Elinder CG. Fehrman-Ekholm I, et al. Transplantation. 2001 Aug 15;72(3):444-9. doi: 10.1097/00007890-200108150-00015. Transplantation. 2001. PMID: 11502974

10

Serum cystatin C: a useful marker of kidney function in very old people.

Fehrman-Ekholm I, Seeberger A, Björk J, Sterner G. Fehrman-Ekholm I, et al. Scand J Clin Lab Invest. 2009;69(5):606-11. doi: 10.1080/00365510903015771. Scand J Clin Lab Invest. 2009. PMID: 19517296 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters